GHIT Fund: Product Development Platform
Application deadline
Latest EOI deadline: 10 July (stage 2 - by invitation only closing 7 August)
Award volume and duration
Volume varies; up to 2 years
About the call
The GHIT Fund invests in the research and development of new health technologies, including drugs, vaccines and diagnostics, for infectious diseases prevalent in low-income countries (LICs) and lower-middle-income countries (LMICs). The Product Development Platform offers support for innovative global health research and development including: 1) lead optimization, 2) preclinical development, 3) clinical development, 4) parallel or concurrent development of multiple interventions, and 5) activities to support licensure and WHO prequalification.
